New Drug Shows Promise in Slowing Alzheimer's Symptoms

TEHRAN (Tasnim) – International pharmaceutical company Eli Lilly revealed promising results from its Phase 3 donanemab trials, indicating that the drug significantly slowed cognitive and functional decline in participants with early Alzheimer's.

2023-09-01 15:19:40
 0  370137
New Drug Shows Promise in Slowing Alzheimer's Symptoms

TEHRAN (Tasnim) – International pharmaceutical company Eli Lilly revealed promising results from its Phase 3 donanemab trials, indicating that the drug significantly slowed cognitive and functional decline in participants with early Alzheimer's.

News ID: 16391747